
    
      After an initial 4-week period of once-daily treatment with open-label active LEO 90100
      aerosol foam, subjects who qualify for randomisation will continue into a 52-week maintenance
      treatment period with twice-weekly application of randomised LEO 90100 aerosol foam / LEO
      90100 aerosol foam vehicle.

      If the subject experiences a relapse of psoriasis, the active lesions will be treated for 4
      weeks with open-label active LEO 90100 aerosol foam.
    
  